TITLE:
Safety and Efficacy of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart as Mealtime Insulin in Type 1 Diabetes

CONDITION:
Diabetes

INTERVENTION:
insulin detemir

SUMMARY:

      This trial is conducted in Europe and the United States of America (USA). The purpose of
      this study is to test whether insulin detemir is a safe and at least as effective
      alternative to insulin glargine for the control of blood glucose in basal/bolus therapy in
      patients with type I diabetes.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Type 1 diabetes for at least 12 months

          -  Current treatment with basal-bolus insulin regimen for more than or equal to 3 months

          -  HbA1c less than or equal to 11.0%

        Exclusion Criteria:

          -  Proliferative retinopathy or maculopathy

          -  Recurrent major hypoglycaemia

          -  Impaired hepatic or renal function

          -  Cardiac problems or uncontrolled hypertension
      
